Evidence map›Paper›PMID 33633603›Full record

ArticleFrontiers in psychiatry2021

Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study.

Jennifer H Foss-Feig, Sylvia B Guillory, Brian J Roach, Eva Velthorst, Holly Hamilton, Peter Bachman, Aysenil Belger, Ricardo Carrion, Erica Duncan, Jason Johannesen and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Autism spectrum disorder and schizophrenia: An updated conceptual review.Autism research : official journal of the International Society for Autism Research · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 13 institutions in 2 countries.

Jennifer H Foss-FeigDepartment of Psychiatry and Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Sylvia B GuilloryDepartment of Psychiatry and Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Brian J RoachSan Francisco VA Health Care System, San Francisco, CA, United States.
Eva VelthorstDepartment of Psychiatry and Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Holly HamiltonSan Francisco VA Health Care System, San Francisco, CA, United States.
Peter BachmanDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, PA, United States.
Aysenil BelgerDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, United States.
Ricardo CarrionDepartment of Psychiatry, Zucker Hillside Hospital, New York, NY, United States.
Erica DuncanDepartments of Psychology and Psychiatry, Atlanta VA Health Care System and Emory University, Decatur, GA, United States.
Jason JohannesenDepartments of Psychology and Psychiatry, Yale University, New Haven, CT, United States.
Gregory A LightDepartment of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Margaret NiznikiewiczDepartment of Psychiatry, Harvard University, Cambridge, MA, United States.
Jean M AddingtonDepartment of Psychiatry, University of Calgary, Calgary, AB, Canada.
Kristin S CadenheadDepartment of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Tyrone D CannonDepartments of Psychology and Psychiatry, Yale University, New Haven, CT, United States.
Barbara CornblattDepartment of Psychiatry, Zucker Hillside Hospital, New York, NY, United States.
Thomas McGlashanDepartments of Psychology and Psychiatry, Yale University, New Haven, CT, United States.
Diana PerkinsDepartment of Psychiatry, University of North Carolina, Chapel Hill, NC, United States.
Larry J SeidmanDepartment of Psychiatry, Harvard University, Cambridge, MA, United States.
William S StoneDepartment of Psychiatry, Harvard University, Cambridge, MA, United States.
Ming TsuangDepartment of Psychiatry, University of California, San Diego, San Diego, CA, United States.
Elaine F WalkerDepartments of Psychology and Psychiatry, Atlanta VA Health Care System and Emory University, Decatur, GA, United States.
Scott WoodsDepartments of Psychology and Psychiatry, Yale University, New Haven, CT, United States.
Carrie E BeardenDepartments of Psychiatry and Biobehavioral Sciences and Psychology, University of California, Los Angeles, Los Angeles, CA, United States.
Daniel H MathalonSan Francisco VA Health Care System, San Francisco, CA, United States.
Yale University · USHarvard University · USIcahn School of Medicine at Mount Sinai · USUniversity of California, San Diego · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USZucker Hillside Hospital · USAtlanta VA Health Care System · USEmory University · USSan Francisco VA Health Care System · USUniversity of Calgary · CAUniversity of California, Los Angeles · USUniversity of Pittsburgh · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
STRESS AND EMOTIONAL REACTIVITYP50MH066286 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YEE-BRADBURY, CINDY M. · 2003 to 2014
$18.6M
1/9 Predictors and Mechanisms of Conversion to PsychosisU01MH081902 · NIMH · YALE UNIVERSITY · PI CANNON, TYRONE D · 2008 to 2018
$12.4M
Vulnerability to Progression SchizophreniaP50MH080272 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI WOO, TSUNGUNG · 2007 to 2011
$9.9M
Preclinical CoreP50HD103573 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GABRIEL S DICHTER · 2020 to 2026
$9.7M
5/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082004 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PERKINS, DIANA O. · 2008 to 2018
$7.5M
Administrative Supplement Harmonization of At Risk Multisite Observational Networks for Youth(HARMONY)U01MH081928 · NIMH · BETH ISRAEL DEACONESS MEDICAL CENTER · PI STONE, WILLIAM SETH · 2008 to 2018
$7.1M
4/9-Predictors and Mechanisms of Conversion to PsychosisU01MH081857 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI CORNBLATT, BARBARA A. · 2008 to 2018
$6.2M
8/9 Predictors and Mechanisms of Conversion to PsychosisU01MH082022 · NIMH · YALE UNIVERSITY · PI WOODS, SCOTT W · 2008 to 2018
$6.0M
2/9 - Predictors and Mechanisms of Conversion to PsychosisU01MH081988 · NIMH · EMORY UNIVERSITY · PI WALKER, ELAINE FRAN · 2008 to 2018
$5.4M
"7/9" Predictors and Mechanisms of Conversion to PsychosisU01MH081984 · NIMH · UNIVERSITY OF CALGARY · PI ADDINGTON, JEAN M · 2008 to 2018
$4.2M
PROMIS-guided development and validation of a dimensional observer-report measure of positive and negative features of ASDR01MH119172 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FOSS-FEIG, JENNIFER · 2019 to 2023
$4.1M
CSRD VA I01 CX000974NCATS NIH HHS TL1 TR001434NCATS NIH HHS UL1 TR001863NICHD NIH HHS P50 HD103573NIMH NIH HHS K24 MH076191NIMH NIH HHS P50 MH066286NIMH NIH HHS P50 MH080272NIMH NIH HHS R01 MH060720NIMH NIH HHS R01 MH117315NIMH NIH HHS R01 MH119172NIMH NIH HHS R21 MH115297NIMH NIH HHS R21 MH117512NIMH NIH HHS U01 MH076989NIMH NIH HHS U01 MH081857NIMH NIH HHS U01 MH081902NIMH NIH HHS U01 MH081928NIMH NIH HHS U01 MH081984NIMH NIH HHS U01 MH081988NIMH NIH HHS U01 MH082004NIMH NIH HHS U01 MH082022
6 · The paper itself

Abstract

Psychosis rates in autism spectrum disorder (ASD) are 5-35% higher than in the general population. The overlap in sensory and attentional processing abnormalities highlights the possibility of related neurobiological substrates. Previous research has shown that several electroencephalography (EEG)-derived event-related potential (ERP) components that are abnormal in schizophrenia, including P300, are also abnormal in individuals at Clinical High Risk (CHR) for psychosis and predict conversion to psychosis. Yet, it is unclear whether P300 is similarly sensitive to psychosis risk in help-seeking CHR individuals with ASD history. In this exploratory study, we leveraged data from the North American Prodrome Longitudinal Study (NAPLS2) to probe for the first time EEG markers of longitudinal psychosis profiles in ASD. Specifically, we investigated the P300 ERP component and its sensitivity to psychosis conversion across CHR groups with (ASD+) and without (ASD-) comorbid ASD. Baseline EEG data were analyzed from 304 CHR patients (14 ASD+; 290 ASD-) from the NAPLS2 cohort who were followed longitudinally over two years. We examined P300 amplitude to infrequent Target (10%; P3b) and Novel distractor (10%; P3a) stimuli from visual and auditory oddball tasks. Whereas P300 amplitude attenuation is typically characteristic of CHR and predictive of conversion to psychosis in non-ASD sample, in our sample, history of ASD moderated this relationship such that, in CHR/ASD+ individuals, enhanced - rather than attenuated - visual P300 (regardless of stimulus type) was associated with psychosis conversion. This pattern was also seen for auditory P3b amplitude to Target stimuli. Though drawn from a small sample of CHR individuals with ASD, these preliminary results point to a paradoxical effect, wherein those with both CHR and ASD history who go on to develop psychosis have a unique pattern of enhanced neural response during attention orienting to both visual and target stimuli. Such a pattern stands out from the usual finding of P300 amplitude reductions predicting psychosis in non-ASD CHR populations and warrants follow up in larger scale, targeted, longitudinal studies of those with ASD at clinical high risk for psychosis.

Indexed as

autism spectrum disorderconversionEEGP300prodromepsychosis

Identifiers

PMID33633603
PMCPMC7901571
OpenAlexW3126451973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.